We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals

57 hedge funds and large institutions have $79.8M invested in Syndax Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

61.15% more ownership

Funds ownership: 0%61.15% (+61%)

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

27% more funds holding

Funds holding: 4557 (+12)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

55% less capital invested

Capital invested by funds: $176M → $79.8M (-$95.9M)

Holders
57
Holders Change
+12
Holders Change %
+26.67%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
15
Reduced
11
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
51
UBS Group
Switzerland
$6K -$89.7K -8,189 -91%
Bank of America
52
Bank of America
North Carolina
$5K -$2.2K -201 -24%
MAM
53
Meeder Asset Management
Ohio
$2K +$2.37K +216 New
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$2K +$2.98K +272 New
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K +$1.06K +97 New
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$466 -$2.81K -256 -80%
GE
57
General Electric
Ohio
-$726K -47,945 Closed
AA
58
ALPS Advisors
Colorado
-$344K -22,669 Closed
LCM
59
Laurion Capital Management
New York
-$305K -20,091 Closed
Citigroup
60
Citigroup
New York
-$4.16K -380 -99%